Prusogliptin

Last updated
Prusogliptin
Prusogliptin.svg
Clinical data
Other namesDBPR108
Legal status
Legal status
  • Investigational
Identifiers
  • (2S,4S)-4-Fluoro-1-[2-[(2-methyl-4-oxo-4-pyrrolidin-1-ylbutan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C16H25FN4O2
Molar mass 324.400 g·mol−1
3D model (JSmol)
  • CC(C)(CC(=O)N1CCCC1)NCC(=O)N2C[C@H](C[C@H]2C#N)F
  • InChI=1S/C16H25FN4O2/c1-16(2,8-14(22)20-5-3-4-6-20)19-10-15(23)21-11-12(17)7-13(21)9-18/h12-13,19H,3-8,10-11H2,1-2H3/t12-,13-/m0/s1
  • Key:VQKSCYBKUIDZEI-STQMWFEESA-N

Prusogliptin (DBPR108) is an experimental DPP-4 inhibitor developed by CSPC Pharmaceutical Group to treat type 2 diabetes. [1] [2] [3]

Related Research Articles

<i>The Emperor in Han Dynasty</i> 2005 Chinese television series

The Emperor in Han Dynasty, also released under the title The Emperor Han Wu in some countries, is a 2005 Chinese historical drama television series based on the life of Emperor Wu of the Han dynasty. It uses the historical texts Records of the Grand Historian and Book of Han as its source material.

<i>Romance of the Three Kingdoms</i> (TV series) Chinese television series

Romance of the Three Kingdoms is a Chinese television series adapted from the classical 14th century novel of the same title by Luo Guanzhong. The series was produced by China Central Television (CCTV) and was first aired on the network in 1994. It spanned a total of 84 episodes, each approximately 45 minutes long. One of the most expensive television series produced at the time, the project was completed over four years and involved over 400,000 cast and crew members, including divisions of the People's Liberation Army from the Beijing, Nanjing and Chengdu military regions. Some of the dialogue spoken by characters was adapted directly from the novel. Extensive battle scenes, such as the battles of Guandu, Red Cliffs and Xiaoting, were also live-acted.

<i>Three Kingdoms</i> (TV series) 2010 Chinese historical series

Three Kingdoms is a 2010 Chinese television series based on the events in the late Eastern Han dynasty and the Three Kingdoms period. The plot is adapted from the 14th century historical novel Romance of the Three Kingdoms and other stories about the Three Kingdoms period. Directed by Gao Xixi, the series had a budget of over 160 million RMB and took five years of pre-production work. Shooting of the series commenced in October 2008, and it was released in China in May 2010.

<span class="mw-page-title-main">Leonurine</span> Chemical compound

Leonurine is a pseudoalkaloid that has been isolated from Leonotis leonurus, Leonotis nepetifolia, Leonurus japonicus, Leonurus cardiaca (motherwort), Leonurus sibiricus, as well as other plants of family Lamiaceae. Leonurine is easily extracted into water.

<i>Royal Tramp</i> (TV series) Chinese TV series or program

Royal Tramp is a 2008 Chinese television series adapted from Louis Cha's novel The Deer and the Cauldron. Produced by Zhang Jizhong and Huayi Brothers, the series consists of 50 episodes, filmed in high definition. The series was first broadcast on Jiangsu TV in China in 2008 and was subsequently aired on TVB in Hong Kong and other countries.

<i>The Legend and the Hero</i> 2007 Chinese television series

The Legend and the Hero is a 2007 Chinese television series adapted from the 16th-century novel Fengshen Yanyi written by Xu Zhonglin and Lu Xixing. The first season started airing on CCTV-8 in February 2007. It was followed by a sequel, The Legend and the Hero 2 in 2009.

<i>Letter 1949</i> Taiwanese TV series or program

Letter 1949 is a 2008 Taiwanese drama starring Queenie Tai, Lin Yo-wei, Alien Huang, Hawick Lau. It was produced by Eastern Shine Production. The series was broadcast on free-to-air Chinese Television System (CTS) from 9 to 26 November 2008, Monday to Thursday at 20:00.

<i>The Han Triumph</i> Chinese television series

The Han Triumph, also known as Wind Ode, is a Chinese television series based on historical events in the early Han dynasty, beginning with the founding of the dynasty by Liu Bang after his triumph over Xiang Yu, and the events leading to the reign of Liu Heng. Directed by Huang Jianzhong, the series starred Ray Lui, Wang Ji, Liu Mu, Zhang Guangbei, Chen Wei and Li Qingxiang in the leading roles. It was first broadcast on CCTV-8 in China on 17 December 2011.

<i>Justice Bao</i> (2010 TV series) Chinese television series

Justice Bao is a Chinese TV series starring producer Jin Chao-chun as the Song dynasty official Bao Zheng. The series ran for 3 seasons from 2010 to 2012. In addition to Jin, Kenny Ho, Fan Hung-hsuan and Lung Lung again reprise their iconic roles from the 1993 Taiwanese hit Justice Pao and the 2008 Chinese series Justice Bao.

<i>Tang Ming Huang</i> (TV series) 1990 Chinese television series

Tang Ming Huang is a Chinese television series based on historical events in the reign of Emperor Xuanzong of the Tang dynasty. The series was directed by Chen Jialin and starred Liu Wei as the eponymous emperor. It was first broadcast on CCTV-1 in 1990 in mainland China.

<i>The Heart of Woman</i> Taiwanese TV series or program

The Heart of Woman, also known as Women, is a Taiwanese Hokkien television series that began airing on SET Taiwan in Taiwan on 21 November 2012, from Mondays to Fridays, and ends on 21 November 2013, lasting one year with a total of 262 episodes.

The Sound of Happiness is a Taiwanese Hokkien television drama that began airing on SET Taiwan in Taiwan on 26 December 2018, from Mondays to Fridays, and ended its broadcast on 5 August 2020. The series started production on 22 November 2018. The series is aired every weeknight at 8pm and is simulcast one hour later on SET Taiwan's sister channel, SET Drama.

Sulfidogermanates or thiogermanates are chemical compounds containing anions with sulfur atoms bound to germanium. They are in the class of chalcogenidotetrelates. Related compounds include thiosilicates, thiostannates, selenidogermanates, telluridogermanates and selenidostannates.

<span class="mw-page-title-main">Fotagliptin</span> Chemical compound

Fotagliptin (SAL067) is a DPP-4 inhibitor under development for the treatment of type 2 diabetes. Like other DPP-4 inhibitors, it works by increasing endogenously produced GLP-1 and GIP. In a phase 3 trial it showed similar results as alogliptin.

<span class="mw-page-title-main">Famitinib</span> Chemical compound

Famitinib is a tyrosine kinase receptor inhibitor developed by Jiangsu Hengrui for a variety of cancers.

<span class="mw-page-title-main">Janagliflozin</span> Chemical compound

Janagliflozin is an experimental SGLT2 inhibitor developed by Sihuan Pharmaceutical.

References

  1. Xu, Jianping; Ling, Hongwei; Geng, Jianlin; Huang, Yanli; Xie, Ying; Zheng, Huiping; Niu, Huikun; Zhang, Tianhao; Yuan, Jing; Xiao, Xinhua (November 2022). "Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial". Diabetes, Obesity and Metabolism. 24 (11): 2232–2240. doi:10.1111/dom.14810. PMC   9796963 . PMID   35791646.
  2. Yeh, Kai-Chia; Yeh, Teng-Kuang; Huang, Chung-Yu; Hu, Chih-Bo; Wang, Min-Hsien; Huang, Yu-Wen; Chou, Ling-Hui; Ho, Hsuan-Hui; Song, Jen-Shin; Hsu, Tsu; Jiaang, Weir-Torn; Chao, Yu-Sheng; Chen, Chiung-Tong (August 2021). "DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity". Life Sciences. 278: 119574. doi:10.1016/j.lfs.2021.119574. PMID   33961850. S2CID   233999305.
  3. Wang, Wei; Yao, Jun; Guo, Xiaohui; Guo, Yushan; Yan, Chaoli; Liu, Kuanzhi; Zhang, Ying; Wang, Xiaoyue; Li, Hongmei; Wen, Zhongyuan; Wang, Xinling; Li, Shuangqing; Xiao, Xinhua; Liu, Weijuan; Li, Ziling; Zhang, Lihui; Shao, Shiying; Ye, Shandong; Qin, Guijun; Li, Yiming; Li, Feng; Zhang, Xiaomei; Li, Xuefeng; Peng, Yongde; Deng, Hongyan; Xu, Xiangjin; Zhou, Ligang; Huang, Yanli; Cao, Mengya; Xia, Xuefang; Shi, Mingbiao; Dou, Jing; Yuan, Jing (2 July 2020). "Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial". Current Medical Research and Opinion. 36 (7): 1107–1115. doi:10.1080/03007995.2020.1761311. PMID   32338063. S2CID   216555956.